Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 17,926–17,950 of 27,380 studies, newest first · page 718 of 1096.

April 2014 15

  1. 2014-04-01

    Frontotemporal lobar degeneration: a clinical approach

    ✓ Peer-reviewed Drug development Seminars in neurology

    Key finding: In this review, the authors outline a clinical approach to frontotemporal lobar degeneration (FTLD), a term coined to describe a pathology associated with atrophy of the frontal and temporal lobes commonly seen with abnormal protein aggregates. +2 more findings

  2. 2014-04-01

    Optimizing person-centered transitions in the dementia journey: a comparison of national dementia strategies

    ✓ Peer-reviewed End-of-life care Health affairs (Project Hope)

    Key finding: Adopting a person-centered perspective, we found that most or all of the national strategies adequately address earlier transitions in the journey, but fewer strategies address the later transitions.

  3. 2014-04-01

    Vital conversations with family in the nursing home: preparation for end-stage dementia care

    ✓ Peer-reviewed End-of-life care Journal of social work in end-of-life & palliative care

    Key finding: Family members of persons with advanced dementia may be asked to make complex treatment decisions without having adequate knowledge regarding the risks and benefits.

  4. 2014-04-01

    Advance directives and nursing home stays associated with less aggressive end-of-life care for patients with severe dementia

    ✓ Peer-reviewed End-of-life care Health affairs (Project Hope)

    Key finding: We found that cognitive impairment is common among older adults approaching the end of life, whether they live in the community or in a nursing home, and that nearly 30 percent of patients with severe dementia remained in the community until death. +2 more findings

  5. 2014-04-01

    Factors associated with increased caregivers' burden in several cognitive stages of Alzheimer's disease

    ✓ Peer-reviewed Clinical safety Geriatrics & gerontology international

    Key finding: Multiple factors including BPSD, impaired life function and geriatric syndrome were cognitive stage-dependently associated with CB. +3 more findings

  6. 2014-04-01

    [Insulin resistance and cognitive function]

    ✓ Peer-reviewed Drug development Nihon rinsho. Japanese journal of clinical medicine

    Key finding: Insulin resistance is identified as a pathogenic mechanism of impaired cognitive dysfunction. +3 more findings

  7. 2014-04-01

    [Biomarkers in Alzheimer's disease]

    ✓ Peer-reviewed Tau biomarkers Revista de neurologia

    Key finding: Three CSF biomarkers, Aß42, total tau, and phosphorylated tau, reflect the core pathological features of AD. +3 more findings

  8. 2014-04-01

    Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry

    ✓ Peer-reviewed Tau biomarkers JAMA neurology

    Key finding: Identifying a clinical distinction between the invariably lethal prion disease Creutzfeldt-Jakob disease (CJD) and nonprion rapidly progressive dementias is important and sometimes difficult; thus, reliable tools for diagnosis are in great demand. +3 more findings

  9. 2014-04-01

    The genetics of Alzheimer's disease

    ✓ Peer-reviewed TREM2 and immune genetics Clinical interventions in aging

    Key finding: Three main genes are involved in early onset AD: amyloid precursor protein (APP), presenilin 1 (PSEN1), and presenilin 2 (PSEN2). +3 more findings

  10. 2014-04-01

    TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis

    ✓ Peer-reviewed Risk genes beyond APOE JAMA neurology

    Key finding: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease in which microglia play a significant and active role. +3 more findings

  11. 2014-04-01

    Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis

    ✓ Peer-reviewed Risk genes beyond APOE JAMA neurology

    Key finding: The AD brain is characterized microscopically by the combined presence of 2 classes of abnormal structures, extracellular amyloid plaques and intraneuronal neurofibrillary tangles, both of which comprise highly insoluble, densely packed filaments. +3 more findings

  12. 2014-04-01

    Pharmacological treatment of Parkinson disease: a review

    ✓ Peer-reviewed Risk factors JAMA

    Key finding: Although levodopa is the most effective medication available for treating the motor symptoms of Parkinson disease, in certain instances (eg, mild symptoms, tremor as the only or most prominent symptom, aged Conclusions and relevance Strong evidence supports using levodopa and dopamine agonists for motor symptoms at all stages of Parkinson disease.

  13. 2014-04-01

    Pseudo-dementia: A neuropsychological review

    ✓ Peer-reviewed Digital health tools Annals of Indian Academy of Neurology

    Key finding: Thus, it is important to have a detailed knowledge of the cognitive or neuropsychological deficits in this condition. +4 more findings

  14. 2014-04-01

    Dementia prevalence and care in assisted living

    ✓ Peer-reviewed Disparities Health affairs (Project Hope)

    Key finding: Estimates derived from national data indicate that seven out of ten residents in these residences have some form of cognitive impairment, with 29 percent having mild impairment, 23 percent moderate impairment, and 19 percent severe impairment.

  15. 2014-04-01

    Synergistic effects of ischemia and β-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairment

    ✓ Peer-reviewed Brain scans and imaging JAMA psychiatry

    Key finding: Most patients with svMCI do not exhibit substantial amyloid burden, and CVD does not increase β-amyloid burden as measured by amyloid imaging. +4 more findings

March 2014 10

  1. 2014-03-31

    Cognitive functioning and late-life depression

    ✓ Peer-reviewed Risk factors Journal of the International Neuropsychological Society : JINS

    Key finding: This brief report provides an introduction to the topic of cognitive functioning in late-life depression (LLD). +3 more findings

  2. 2014-03-31

    Why looking at the whole hippocampus is not enough-a critical role for anteroposterior axis, subfield and activation analyses to enhance predictive value of hippocampal changes for Alzheimer's disease diagnosis

    ✓ Peer-reviewed Hippocampus size on brain scans Frontiers in cellular neuroscience

    Key finding: Finally, we indicate that apart from hippocampal subfield volumetry, the characteristic pattern of hippocampal hyperactivation associated with seizures and neurogenesis changes is another promising candidate for an early AD biomarker that could become also a target for early interventions.

  3. 2014-03-31

    Review of brief cognitive tests for patients with suspected dementia

    ✓ Peer-reviewed Cognitive tests and assessment International psychogeriatrics

    Key finding: As the population ages, it is increasingly important to use effective short cognitive tests for suspected dementia. +3 more findings

  4. 2014-03-31

    Benefit-finding intervention for Alzheimer caregivers: conceptual framework, implementation issues, and preliminary efficacy

    ✓ Peer-reviewed Treatments The Gerontologist

    Key finding: Controlling for pretest, the benefit-finding group had lower depression than the psychoeducation group at post-test, despite the fact that some caregivers found benefit-finding challenging. +2 more findings

  5. 2014-03-30

    Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis

    ✓ Peer-reviewed Lewy body dementia Nature neuroscience

    Key finding: MATR3 is an RNA- and DNA-binding protein that interacts with TDP-43, a disease protein linked to amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. +3 more findings

  6. 2014-03-27

    Differential effects of angiotensin II receptor blockers on Aβ generation

    ✓ Peer-reviewed Biomarkers Neuroscience letters

    Key finding: Here, we studied the effect of ARBs on Aβ generation and found that telmisartan significantly increased Aβ40 and Aβ42 generation, but decreased the Aβ42/Aβ40 ratio. +2 more findings

  7. 2014-03-27

    Epidemiology and outcomes in community-acquired versus hospital-acquired AKI

    ✓ Peer-reviewed Risk factors Clinical journal of the American Society of Nephrology : CJASN

    Key finding: The incidence of CA-AKI among all hospital admissions was 4.3% compared with an incidence of 2.1% of HA-AKI, giving an overall AKI incidence of 6.4%. +1 more finding

  8. 2014-03-26
  9. 2014-03-25

    Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease

    ✓ Peer-reviewed Down syndrome and Alzheimer's Free radical biology & medicine

    Key finding: We suggest that a group of identified proteins followed a specific pattern of oxidation in DS vs young controls, probably indicating characteristic features of the DS phenotype; a second group of identified proteins showed increased oxidation in DS/AD vs DS, thus possibly playing a role in the development of AD. +2 more findings

  10. 2014-03-25

    Multivariate models of subjective caregiver burden in dementia: a systematic review

    ✓ Peer-reviewed Caregiving Ageing research reviews

    Key finding: We found 32 studies with burden models and 24 depression and mental health models. +1 more finding

Browse the library by subject, with the full score breakdown →